APP and Alzheimer disease: The Arctic mutation (E693G) in amyloid precursor protein (APP), which was discovered in a Swedish family showing clinical symptoms of early-onset AD [9], has been shown to accelerate Aβ protofibril formation in vitro, a soluble intermediate oligomer of Aβ fibrillization, and intraneuronal Aβ aggregation in model mice [10,11].